Skip to main content
Daniel Geschwind, MD, Neurology, Los Angeles, CA

Daniel Hal Geschwind MD

Hospital/Neurohospitalist, Neurodevelopmental Disabilities


Professor of Neurology and Psychiatry at the David Geffen School of Medicine at UCLA. He is director of the Neurogenetics Program and the Center for Autism Research and Treatment (CART) and co-director of the Center for Neurobehavioral Genetics.

Join to View Full Profile
  • 695 Charles E Young Drive, Gonda 2506Los Angeles, CA 90095

  • Phone+1 310-794-6570

  • Fax+1 310-794-6570

Dr. Geschwind is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1992 - 1995
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1991 - 1992
  • Yale School of Medicine
    Yale School of MedicineClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - 2026
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2011
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Integrative Network Analysis Reveals Biological Pathways Associated with Williams Syndrome  
    Michael J Gandal, Daniel H Geschwind, Journal of Child Psychology and Psychiatry
  • Autism-like Phenotype and Risk Gene mRNA Deadenylation by CPEB4 Mis-Splicing  
    Daniel H Geschwind, Neelroop N Parikshak, Nature
  • Author Correction: Genome-Wide Changes in lncRNA, Splicing, and Regional Gene Expression Patterns in Autism  
    Daniel H Geschwind, Michael J Gandal, Nature
  • Join now to see all

Press Mentions

  • Researchers Uncover Shared Cellular Mechanisms Across Three Major Dementias
    Researchers Uncover Shared Cellular Mechanisms Across Three Major DementiasSeptember 11th, 2024
  • Researchers at UCLA Found That Autism-Related Brain Changes Are Present Throughout the Cerebral Cortex, a Finding That Redefines Scientists’ Previous Understanding of Autism on a Molecular Level
    Researchers at UCLA Found That Autism-Related Brain Changes Are Present Throughout the Cerebral Cortex, a Finding That Redefines Scientists’ Previous Understanding of Autism on a Molecular LevelNovember 13th, 2022
  • Brain Changes in Autism Are Far More Extensive Than Previously Known
    Brain Changes in Autism Are Far More Extensive Than Previously KnownNovember 5th, 2022
  • Join now to see all

Grant Support

  • UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
  • Autism Genetics Phase II: Increasing Representation of Human DiversityUNIVERSITY OF CALIFORNIA LOS ANGELES2013–2028
  • Autism Genetics Phase II: Increasing Representation of Human DiversityUNIVERSITY OF CALIFORNIA LOS ANGELES2013–2028
  • Autism Genetics Phase II: Increasing Representation of Human DiversityUNIVERSITY OF CALIFORNIA LOS ANGELES2013–2028
  • Autism Genetics Phase II: Increasing Representation of Human DiversityUNIVERSITY OF CALIFORNIA LOS ANGELES2013–2028
  • Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSPICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2026
  • Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSPICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2026
  • Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSPICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2026
  • Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSPICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2026
  • Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSPICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2026
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • High-throughput modeling of autism risk genes using zebrafishCALIFORNIA INSTITUTE OF TECHNOLOGY2020–2025
  • 2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disordersUNIVERSITY OF CALIFORNIA LOS ANGELES2018–2025
  • A Comprehensive Approach To Identification Of Autism Susceptibility GenesNational Institute Of Mental Health2008–2012
  • Epigenetic And Transcriptional Dysregulation In Autism Spectrum DisorderNational Institute Of Mental Health2011
  • Neurogenomics/Bioinformatics CoreEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
  • GeneticsNational Institute On Aging2007–2011
  • Genetics Of Language &Social Communication:Connecting Genes To Brain &CognitionEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
  • Training Grant In Neurobehavioral GeneticsNational Institute Of Mental Health2006–2011
  • Identification And Characterization Of Asymmetrically-Expressed GenesNational Institute Of Mental Health2006–2011
  • Transcriptional Atlas Of Human Brain DevelopmentNational Institute Of Mental Health2009–2010
  • Providing Core Support For Jr. Faculty For Translational Research In ASDNational Institute Of Mental Health2009–2010
  • Novel Genetic Risk Factors For Alzheimer'S Disease (AD) &Frontotemporal DementiaNational Institute On Aging2007–2009
  • Identification Of Novel Genetic Risk Factors For AD And*National Institute On Aging2006
  • Identification Of Targets Of FOXP2 In The BrainNational Institute Of Mental Health2005–2006
  • A Genomewide Search For Autism Susceptibilty LociNational Institute Of Mental Health2002–2006
  • Identification Of Genetic Risk Factors For AD And FTDNational Institute On Aging2005
  • Asymmetrically-Expressed Genes In Developing Human CerebrumNational Institute Of Mental Health2005
  • The Genetics Of Idiopathic Basal Ganglia CalcificationNational Institute Of Neurological Disorders And Stroke2001–2004
  • Genomewide Search--Autism Susceptibility Loci-SupplementNational Institute Of Mental Health2003
  • Asymmetrically Expressed Genes In Developing CerebrumNational Institute Of Mental Health2000–2003
  • Asymmetrically Expressed Genes In The Developing CerebruNational Institute Of Mental Health1999
  • Localization Of A Gene Underlying Cerebral LateralityNational Institute Of Neurological Disorders And Stroke1995–1999

Other Languages

  • French

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: